When the liver is damaged by chronic diseases, it has the ability to regenerate itself. Cancer, however, can develop during the regeneration process. A team of researchers led by Ludovic Vallier, Einstein Professor for Stem Cells in Regenerative Therapies at the Berlin Institute of Health at Charité…
In cooperation with the BIH QUEST Center, the Einstein Foundation Berlin honors the Dutch microbiologist Elisabeth Bik, the platform PubPeer, and the initiative PixelQuality with the Einstein Foundation Award for Promoting Quality in Research 2024.
The European Rare Diseases Research Alliance (ERDERA) is holding today, October 28, its official launch event, where it will set out its vision and ambition for tackling rare diseases as part of the EU’s research strategy in this field. Representatives of the European Commission, patients’…
UNFPA, the United Nations Population Fund, will launch its new “WomenX Collective” programme at the World Health Summit in Berlin on October 14, followed the next day by the opening of its first hub office in a planned global network of centres specializing in the promotion of women's health,…
Prof. Christian Gaebler, an HIV researcher at Charité – Universitätsmedizin Berlin, has a goal: to develop treatments that cure HIV infection in patients or prompt the immune system to keep the virus in check in the long term, even without medications.
A new collaborative study by researchers from the Berlin Institute of Health at Charité (BIH), Queen Mary University of London, University College London, University of Cambridge and the pharmaceutical company GlaxoSmithKline (GSK) shows that proteins measured in a single drop of blood can predict…
Immunotherapies harness the body’s immune system to fight cancer by influencing the interaction between immune cells and cancer cells. Such treatments have proved successful in combating certain types of cancers like leukemia, but they remain ineffective in some patients and cause resistance. A…
The European Molecular Biology Organization (EMBO) has elected Professor Claudia Langenberg of the Berlin Institute of Health at Charité (BIH), and of the Precision Healthcare University Research Institute (PHURI) at Queen Mary University of London, as a new member. Headquartered in Heidelberg,…
Multiple myeloma is one of the most common forms of cancer of the immune cells in the bone marrow. It is considered incurable. Even when patients respond to treatment at first, the cancer comes back. To be able to intervene faster and on a more targeted basis, researchers at Charité –…
The course of SARS-CoV-2 coronavirus infections depends not only on how aggressive the virus is, but also on the immune response of the infected individual. Using single-cell analyses, a group of researchers led by Samantha Praktiknjo of the Berlin Institute of Health at Charité (BIH), Markus…
Today, the Berlin Institute of Health at Charité (BIH) officially handed over the National Strategy for Gene and Cell Therapies to Federal Research Minister Bettina Stark-Watzinger (FDP). Some 150 experts from various stakeholder groups drew up the paper and developed a road map for improving…
Scientists from the Berlin Institute of Health at Charité (BIH) and Open Targets together with colleagues from the University of Cambridge, and Addenbrooke’s Hospital in Cambridge, UK, uncovered mechanisms driving regeneration of the liver during chronic liver disease. This regenerative process…
Researchers at the Berlin Institute of Health at Charité (BIH) have used brain simulations to develop a theory on the formation of traveling waves of activity. These waves influence cognitive processes in the human brain such as learning or remembering. Understanding traveling waves of activity can…
In March 2024, Dr. Simon Haas received a funding commitment from the German Research Association (DFG) for a Heisenberg professorship in systems hematology at the Berlin Institute of Health at Charité (BIH). Haas, who leads a lab within the joint research focus of the BIH, Charité –…
Dr. Christian Meisel, a physician and neuroscientist at the Berlin Institute of Health at Charité (BIH) and Charité – Universitätsmedizin Berlin, has been awarded funding for an endowed chair of computational neurology from the Hermann and Lilly Schilling Foundation for Medical Research. The…
New findings reveal that the body undergoes significant, systematic changes across multiple organs during prolonged periods of fasting. The results demonstrate evidence of health benefits beyond weight loss, but also show that any potentially health-altering changes appear to occur only after three…
In January 2024, Prof. Peter N. Robinson will take up an Alexander von Humboldt Professorship for Artificial Intelligence at the Berlin Institute of Health at Charité (BIH). Robinson, a bioinformatician, is a pioneer in the computational genome and phenotype analysis of genetic diseases. His major…
